Brief: Lipocine Announces Financial Results For The Third Quarter
09/11/2022 14:23
Nov 9 (Reuters) - Lipocine Inc LPCN.O :
* LIPOCINE ANNOUNCES FINANCIAL RESULTS FOR THE THIRD QUARTER
ENDED
SEPTEMBER 30, 2022
* LIPOCINE INC Q3 LOSS PER SHARE $0.03
* LIPOCINE INC - AS OF SEPTEMBER 30, 2022, CO HAD $34.3
MILLION OF
UNRESTRICTED CASH, CASH EQUIVALENTS, MARKETABLE INVESTMENT
SECURITIES
Source text for Eikon: ID:nPnb6tkb4a
Further company coverage: LPCN.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Lipocine
See all newsUS STOCKS ON THE MOVE-Halozyme, Moderna, Merck
U.S. STOCKS ON THE MOVE-Halozyme, BKV, AppFolio
U.S. STOCKS ON THE MOVE-Hecla Mining, XPO, Lipocine
Lipocine surges after Canada approves co's testosterone replacement therapy
Brief: Lipocine Announces Health Canada Approval Of Tlando For Testosterone Replacement Therapy